Kronos Bio’s Investigational SYK Inhibitors Entospletinib and Lanraplenib to be Featured in Four Poster Presentations at EHA2022 Congress
Posters include preclinical data on SYK inhibition in combination with targeted agents and demonstrate preclinical…
Fastlane Launches AI Marketing Platform That Researches, Creates and Runs Campaigns End to End